The absolute void of any discussion on Ivermectin

Bits and pieces just like this keep pouring through my inbox: ‘We Made a Big Mistake’ — COVID Vaccine Spike Protein Travels From Injection Site, Can Cause Organ Damage.

All this is beyond my expertise, but there are lots like it.

Meanwhile, no one in the media, no matter how supposedly on the conservative side of things, ever says a word about Ivermectin. And even though I am aware that the various “vaccines” were developed at the instigation of Donald Trump, whose judgment I normally trust, there are lots of issues that need to be raised and as many questions that need an answer.

But really, why does no one ask about Ivermectin or say a word in public even though there are article like this within easy reach? – A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness, dated February 2021, [“Int J Infect Dis. 2021 Feb;103:214-216. doi: 10.1016/j.ijid.2020.11.191. Epub 2020 Dec 2.”]

This entry was posted in COVID-19, Media. Bookmark the permalink.

3 Responses to The absolute void of any discussion on Ivermectin

  1. Tezza says:

    I tried to observe, in reader comments in ‘The Australian’, that India’s experience by region with Ivermectin and with vaccination would repay some study. Not wildly irresponsible, one would think. However the comment was rejected. I suspect the mere use of the work Ivermectin triggers filters on many websites. Why? In some cases that’s obvious vested interest. But in general discussion, it’s puzzling (at least to me).

  2. Matt says:

    Firstly, the authors themselves note ‘Although the study sample was too small (n = 72) to draw any solid conclusions.’
    But what does the study actually show:
    Any reduction in hospitalisation?
    The mean duration of hospitalization after treatment was 9.7 days (95% confidence interval (CI) 8.1–11.0 days) in the placebo group, 10.1 days (95% CI 8.5–11.8 days) in the ivermectin + doxycycline group, and 9.6 days (95% CI 7.7–11.7 days) in the ivermectin alone group (p = 0.93).

    What about symptoms?
    Of note, these changes were not statistically significant for fever (p = 0.35 and p = 0.09), cough (p = 0.18 and p = 0.23), or sore throat (p = 0.35 and p = 0.09) in the ivermectin + doxycycline and the 5-day ivermectin groups when compared with placebo.

    So what did it show?
    The mean duration to viral clearance was 9.7 days (95% CI 7.8–11.8 days) for the 5-day ivermectin arm (p = 0.02), 11.5 days (95% CI 9.8–13.2 days) for the ivermectin + doxycycline (p = 0.27) arm, and 12.7 days (95% CI 11.3–14.2 days) for the placebo group.

    So it resulted in 3 days earlier viral clearance, which didn’t impact on symptoms or hospitalisation.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.